PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis-Reference-Cited by-同舟云学术

PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis

Published:2023-02-01 Issue:2 Volume:26 Page:135-142
ISSN:1369-7137
Container-title:Climacteric
language:en
Short-container-title:Climacteric

Author:

Zhao Y.¹,Ruan X.¹²^ORCID,Cheng J.¹,Xu X.¹,Gu M.¹,Mueck A. O.¹²

Affiliation:

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing, China

2. Department of Women’s Health, University Women’s Hospital and Research Center of Women’s Health, University of Tuebingen, Tuebingen, Germany

Funder

Scientific Research Common Program of Beijing Municipal Commission of Education

Beijing Hospitals Authority Youth Programme

National Natural Science Foundation of China

Beijing Natural Science Foundation

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13697137.2023.2170225

Reference29 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Breast Cancer Treatment

3. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

4. The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology

5. Function and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMP9 drives ferroptosis by regulating GPX4 and iron signaling;iScience;2024-09

2. Ferroptosis as a promising targeted therapy for triple negative breast cancer;Breast Cancer Research and Treatment;2024-06-14

3. The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop;Frontiers in Toxicology;2024-04-17

4. Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies;Cancers;2023-12-06

5. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer;Biomedicine & Pharmacotherapy;2023-12